Agency Information Collection Activities; Submission for OMB Review; Comment Request; Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (OWCP-26), 48193-48194 [2024-12277]
Download as PDF
48193
Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices
Abstract: The Attorney General is
required by statute to ‘‘assure that any
property transferred to a State or local
law enforcement agency . . . will serve
to encourage further cooperation
between the recipient State or local
agency and Federal law enforcement
agencies.’’ 21 U.S.C. 881(e)(3). MLARS
ensures such cooperation by requiring
that all such ‘‘equitably shared’’ funds
be used only for law enforcement
purposes and not be distributed to other
governmental agencies by the recipient
law enforcement agencies. By requiring
that law enforcement agencies that
participate in the Equitable Sharing
Program (Program) file an Equitable
Sharing Agreement and Certification
(ESAC), MLARS can readily ensure
compliance with its statutory
obligations.
The ESAC requires information
regarding the receipt and expenditure of
Program funds from the participating
agency. Accordingly, it seeks
information that is exclusively in the
hands of the participating agency and
governing jurisdiction. This collection
request is classified as a revision due to
updated requirements incorporated in a
revised version of the Guide to
Equitable Sharing for State, Local, and
Tribal Law Enforcement Agencies, in
addition to format changes and deleting
and relabeling some fields.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a previously approved
collection.
2. The Title of the Form/Collection:
Equitable Sharing Agreement and
Certification.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
There is not an agency form number.
The collection instrument is the
Equitable Sharing Agreement and
Certification. The applicable component
within the Department of Justice is the
Money Laundering and Asset Recovery
Section (‘‘MLARS’’), in the Criminal
Division.
4. Affected public who will be asked
or required to respond, as well as the
obligation to respond: Affected Public
State, local and tribal law enforcement
agencies and governing jurisdictions
participating in the Program.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 6,000
respondents will respond to this
collection. The time per response is
approximately .5 hours.
6. An estimate of the total annual
burden (in hours) associated with the
collection: The total annual burden
hours for this collection is
approximately 3,000 hours.
7. An estimate of the total annual cost
burden associated with the collection, if
applicable:
TOTAL BURDEN HOURS
Number of
respondents
Activity
Total annual
responses
Time per
response
(hours)
Total annual
burden
(hours)
Equitable Sharing Agreement and Certification ..................
6,000
1/annually ......
6,000
.5
3,000
Unduplicated Totals ......................................................
6,000
........................
6,000
........................
3,000
If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 4W–218,
Washington, DC.
Dated: May 30, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2024–12250 Filed 6–4–24; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF LABOR
khammond on DSKJM1Z7X2PROD with NOTICES
Frequency
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Authorization Request Form and
Certification/Letter of Medical
Necessity for Compounded Drugs
(OWCP–26)
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Office of
Workers’ Compensation Programs
SUMMARY:
VerDate Sep<11>2014
16:50 Jun 04, 2024
Jkt 262001
(OWCP)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before July 5, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Michelle Neary by telephone at 202–
693–6312, or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: OWCP
will require the claimant’s treating
physician to complete a Form OWCP–26
online before payment will be made for
a compounded drug. The physician will
be required to specify the ingredients in
the compounded drug, indicate whether
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
the compounded drug and each of its
ingredients are medically necessary, and
explain why the claimant cannot use an
FDA-approved drug instead of the
compounded drug being prescribed. The
form will permit the OWCP to more
easily track the volume, type, and
characteristics of compounded drugs
prescribed for claimants. It will allow
additional oversight of the pharmacy
benefit—improving patient safety,
decreasing cost for stakeholders, and
decreasing the risk for fraud, waste, and
abuse. Completed forms will be
reviewed by a clinical pharmacist or
physician before being reviewed for
decision by the individual program
staff. For additional substantive
information about this ICR, see the
related notice published in the Federal
Register on March 26, 2024 (89 FR
21015).
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
E:\FR\FM\05JNN1.SGM
05JNN1
48194
Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OWCP.
Title of Collection: Authorization
Request Form and Certification/Letter of
Medical Necessity for Compounded
Drugs (OWCP–26).
OMB Control Number: 1240–0NEW.
Affected Public: Private Sector—
Businesses or other for-profits.
Total Estimated Number of
Respondents: 78.
Total Estimated Number of
Responses: 490.
Total Estimated Annual Time Burden:
245 hours.
Total Estimated Annual Other Costs
Burden: $0.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Michelle Neary,
Senior Paperwork Reduction Act Analyst.
[FR Doc. 2024–12277 Filed 6–4–24; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 4510–CR–P
VerDate Sep<11>2014
16:50 Jun 04, 2024
Jkt 262001
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Electric
Power Generation, Transmission, and
Distribution Standard for Construction
and General Industry and Electrical
Protective Equipment for Construction
and General Industry
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Occupational
Safety & Health Administration (OSHA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before July 5, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Nicole Bouchet by telephone at 202–
693–0213, or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
information collection requirements
specified in the Electrical Power
Transmission and Distribution Standard
for Construction and the Electric Power
Transmission and Distribution Standard
provide employees with safe work
practices that guard against exposure to
electrical shock hazards in workplace.
For additional substantive information
about this ICR, see the related notice
published in the Federal Register on
March 25, 2024 (89 FR 20703).
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility and
clarity of the information collection; and
(4) ways to minimize the burden of the
collection of information on those who
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
are to respond, including the use of
automated collection techniques or
other forms of information technology.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OSHA.
Title of Collection: Electric Power
Generation, Transmission, and
Distribution Standard for Construction
and General Industry and Electrical
Protective Equipment for Construction
and General Industry.
OMB Control Number: 1218–0253.
Affected Public: Private Sector—
Businesses or other for-profits.
Total Estimated Number of
Respondents: 21,396.
Total Estimated Number of
Responses: 2,067,172.
Total Estimated Annual Time Burden:
394,614 hours.
Total Estimated Annual Other Costs
Burden: $0.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Nicole Bouchet,
Certifying Official.
[FR Doc. 2024–12276 Filed 6–4–24; 8:45 am]
BILLING CODE 4510–26–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: 24–035]
Name of Information Collection: NASA/
KSC Business Opportunities Expo
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of information collection.
AGENCY:
The National Aeronautics and
Space Administration, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
SUMMARY:
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Pages 48193-48194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12277]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26)
ACTION: Notice of availability; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Department of Labor (DOL) is submitting this Office of
Workers' Compensation Programs (OWCP)-sponsored information collection
request (ICR) to the Office of Management and Budget (OMB) for review
and approval in accordance with the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are invited.
DATES: The OMB will consider all written comments that the agency
receives on or before July 5, 2024.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Michelle Neary by telephone at 202-
693-6312, or by email at [email protected].
SUPPLEMENTARY INFORMATION: OWCP will require the claimant's treating
physician to complete a Form OWCP-26 online before payment will be made
for a compounded drug. The physician will be required to specify the
ingredients in the compounded drug, indicate whether the compounded
drug and each of its ingredients are medically necessary, and explain
why the claimant cannot use an FDA-approved drug instead of the
compounded drug being prescribed. The form will permit the OWCP to more
easily track the volume, type, and characteristics of compounded drugs
prescribed for claimants. It will allow additional oversight of the
pharmacy benefit--improving patient safety, decreasing cost for
stakeholders, and decreasing the risk for fraud, waste, and abuse.
Completed forms will be reviewed by a clinical pharmacist or physician
before being reviewed for decision by the individual program staff. For
additional substantive information about this ICR, see the related
notice published in the Federal Register on March 26, 2024 (89 FR
21015).
Comments are invited on: (1) whether the collection of information
is necessary for the proper performance of the functions of the
Department, including whether the information will have practical
utility; (2) if the information will be processed and used in a timely
manner; (3) the accuracy of the agency's estimates of the burden and
[[Page 48194]]
cost of the collection of information, including the validity of the
methodology and assumptions used; (4) ways to enhance the quality,
utility and clarity of the information collection; and (5) ways to
minimize the burden of the collection of information on those who are
to respond, including the use of automated collection techniques or
other forms of information technology.
This information collection is subject to the PRA. A Federal agency
generally cannot conduct or sponsor a collection of information, and
the public is generally not required to respond to an information
collection, unless the OMB approves it and displays a currently valid
OMB Control Number. In addition, notwithstanding any other provisions
of law, no person shall generally be subject to penalty for failing to
comply with a collection of information that does not display a valid
OMB Control Number. See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOL notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Agency: DOL-OWCP.
Title of Collection: Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26).
OMB Control Number: 1240-0NEW.
Affected Public: Private Sector--Businesses or other for-profits.
Total Estimated Number of Respondents: 78.
Total Estimated Number of Responses: 490.
Total Estimated Annual Time Burden: 245 hours.
Total Estimated Annual Other Costs Burden: $0.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Michelle Neary,
Senior Paperwork Reduction Act Analyst.
[FR Doc. 2024-12277 Filed 6-4-24; 8:45 am]
BILLING CODE 4510-CR-P